The Schall Law Firm Invites Shareholders With Losses To Join An Investigation Into Atara Biotherapeutics, Inc. For Securities Fraud
LOS ANGELES, CA / ACCESS Newswire / February 3, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
Atara Biotherapeutics, Inc. Is Being Investigated For Securities Law Violations And Affected Investors Are Urged To Contact The Schall Law Firm
LOS ANGELES, CA / ACCESS Newswire / February 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is ...
Investing6d
Atara stock holds Neutral rating after workforce cut
The company has expressed its commitment to working with the FDA and other parties to secure approval for EBVALLO in the U.S. In addition to these, Atara Biotherapeutics has amended its bylaws ...
BioSpace6d
Atara to Cut Half Its Workforce Following FDA-Related Setbacks
Atara Biotherapeutics’ layoffs could leave the biotech with around 80 employees. The cuts follow news that the FDA rejected Ebvallo, a T cell therapy approved in Europe for a transplant-related blood ...
Investing6d
Atara stock holds Neutral rating after workforce cut
Atara Biotherapeutics, a biopharmaceutical company, disclosed plans to cut about half of its current employees. This decision comes in the wake of the Food and Drug Administration's (FDA) Complete ...
Morningstar4d
Wolf Haldenstein Adler Freeman & Herz LLP announces that it is investigating Atara Biotherapeutics, Inc. for potential violations of securities laws
The investigation concerns whether Atara Biotherapeutics ... license inspection of a third-party manufacturing facility for EBVALLO.” The FDA took the additional step of placing a clinical ...
Morningstar6d
ATRA Investors Have Opportunity to Join Atara Biotherapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm
announces that it is investigating claims on behalf of investors of Atara Biotherapeutics, Inc. ("Atara" or "the Company") (NASDAQ: ATRA) for violations of the securities laws. The investigation ...
pharmaphorum5d
With landmark approval, spotlight on cryogenic logistics intensifies
Following a positive recommendation from Europe’s Committee for Medicinal Products for Human Use (CHMP), the European Commission on Monday 19th December formally approved Atara Biotherapeutics ...